GO:0004549 tRNA-specific ribonuclease activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004549 (tRNA-specific ribonuclease activity) describes the catalysis of phosphodiester bond hydrolysis in tRNA molecules, a molecular function essential for tRNA maturation, quality control, and stress-induced cleavage.
• Angiogenin (ANG) is the founding human member of the RNase A superfamily that exhibits cytotoxic, tRNA-specific ribonuclease activity, linking this function to angiogenesis and cell survival.
• Mitochondrial tRNA processing relies on tRNA-specific ribonucleases, and defects in this activity are associated with mitochondrial dysfunction observed in mitochondrial disease.
• Bacterial toxins such as MazF-mt9 from Mycobacterium tuberculosis and colicin E5 are tRNA-specific endonucleases whose structures and inhibition mechanisms have been characterized, providing insights into substrate recognition.
• tRNA 3'-processing in Saccharomyces cerevisiae involves distinct exo- and endoribonucleases, and the co-evolution of tRNA trailer sequences with these enzymes highlights species-specific adaptations.
• Studying GO:0004549 requires integrating biochemical assays, structural biology, and CRISPR-based models to dissect its roles in translation, stress responses, and disease.
Description
tRNA-specific ribonuclease activity (GO:0004549) is a molecular function defined as the catalysis of phosphodiester bond hydrolysis in tRNA molecules. This activity is fundamental to tRNA biogenesis, where endonucleolytic and exonucleolytic cleavages remove leader and trailer sequences from precursor tRNAs, and to tRNA quality control pathways that degrade aberrant or damaged tRNAs. The function is also deployed in stress responses, where specific ribonucleases cleave tRNAs to generate fragments that modulate translation and signaling. Researchers study GO:0004549 to understand how cells maintain tRNA pool fidelity, how pathogens use tRNA-targeting toxins, and how dysregulation contributes to human disease. The enzymatic activity is found across all domains of life, with well-characterized examples including angiogenin in humans, MazF-mt9 in Mycobacterium tuberculosis, and colicin E5 in Escherichia coli. Because tRNA molecules are central to protein synthesis, any perturbation of their processing or cleavage can have profound effects on cellular proteostasis and viability.
tRNA-specific ribonuclease activity At A Glance
| GO ID | GO:0004549 |
|---|---|
| GO term | tRNA-specific ribonuclease activity |
| Ontology | molecular_function |
| Synonym | tRNA-specific RNase activity |
| Definition | Catalysis of the hydrolysis of phosphodiester bonds in tRNA molecules. |
| Major function | Cleavage and processing of tRNA molecules during maturation, quality control, and stress responses. |
| Representative enzymes | Angiogenin (ANG), MazF-mt9, colicin E5, mitochondrial tRNA processing nucleases. |
| Substrate specificity | tRNA molecules, including precursor tRNAs and mature tRNAs under stress. |
| Biological context | tRNA maturation, mitochondrial tRNA processing, toxin-antitoxin systems, angiogenesis. |
What Is GO:0004549?
In simple terms, GO:0004549 describes the ability of an enzyme to cut tRNA molecules by breaking the chemical bonds that link RNA building blocks. According to the Gene Ontology, this function is defined as the catalysis of the hydrolysis of phosphodiester bonds in tRNA molecules. It encompasses both endonucleolytic cleavage, which cuts within the tRNA chain, and exonucleolytic trimming, which removes nucleotides from the ends, as long as the substrate is a tRNA molecule. This activity is distinct from general ribonucleases because it specifically recognizes structural features of tRNA, such as the L-shaped fold or specific sequences, ensuring targeted processing rather than random degradation.
Why Is tRNA-specific ribonuclease activity Important in Cell Biology?
GO:0004549 is critically important because tRNA molecules are the adaptors that decode mRNA into protein, and their precise processing and regulated cleavage determine the efficiency and fidelity of translation. Dysregulation of tRNA-specific ribonucleases can lead to accumulation of defective tRNAs, mitochondrial dysfunction, and cell death, as seen in mitochondrial disease and cytotoxic stress responses. Moreover, bacterial pathogens exploit tRNA-specific endonucleases as toxins to inhibit host or competitor translation, making these enzymes attractive targets for antimicrobial development. In humans, angiogenin's tRNA-specific ribonuclease activity links this function to angiogenesis and neurodegeneration, underscoring its broad physiological relevance.
• Essential for tRNA maturation: removes 5' leaders and 3' trailers from precursor tRNAs to generate functional tRNAs.
• Maintains mitochondrial function: mitochondrial tRNA processing defects cause mitochondrial dysfunction observed in disease.
• Mediates stress-induced tRNA cleavage: generates tRNA-derived fragments that regulate translation and signaling.
• Contributes to host-pathogen interactions: bacterial toxins such as colicin E5 and MazF-mt9 target tRNAs to inhibit growth.
• Links to angiogenesis and cancer: angiogenin's tRNA-specific ribonuclease activity is cytotoxic and promotes blood vessel formation.
• Involved in bacterial methionine biosynthesis regulation via tRNA-dependent T-box riboswitches.
• Provides targets for antimicrobial therapy: inhibition of tRNA-specific ribonucleases can disarm bacterial toxins.
• Serves as a model for studying enzyme-substrate specificity and RNA recognition.
• Impacts proteostasis: aberrant tRNA cleavage can deplete tRNA pools and impair protein synthesis.
• Enables biotechnological applications: tRNA-specific ribonucleases are tools for RNA manipulation and synthetic biology.
Molecular Mechanism of tRNA-specific ribonuclease activity
Substrate recognition and binding
In simple terms: The enzyme first grabs onto the tRNA molecule by recognizing its unique shape and chemical features.
tRNA-specific ribonucleases achieve specificity through structural complementarity with the L-shaped tRNA fold. For example, angiogenin binds tRNA with high affinity, and its catalytic site is positioned to cleave the tRNA anticodon loop or other accessible regions. MazF-mt9 from Mycobacterium tuberculosis is a tRNA-specific endonuclease that recognizes tRNA through a conserved fold, and its structure reveals a compact dimer with a catalytic triad typical of RNases. Colicin E5 is a tRNA-specific ribonuclease that cleaves tRNA at the anticodon loop, and its activity is inhibited by its cognate immunity protein through direct occlusion of the active site. These examples illustrate that substrate recognition often involves both shape readout and specific nucleotide contacts.
Catalytic mechanism of phosphodiester bond hydrolysis
In simple terms: Once bound, the enzyme cuts the RNA backbone by using water to break a chemical bond.
The hydrolysis of phosphodiester bonds in tRNA is catalyzed by a general acid-base mechanism, often involving histidine and lysine residues. In angiogenin, the catalytic triad His13, Lys40, and His114 is essential for tRNA cleavage, and mutation of these residues abolishes ribonuclease activity. MazF-mt9 uses a similar catalytic mechanism, with conserved residues that coordinate a water molecule for nucleophilic attack on the phosphodiester bond. Colicin E5 also employs a catalytic mechanism that is inhibited by its immunity protein, which binds near the active site and prevents substrate access. These studies highlight the conserved chemistry of tRNA-specific ribonucleases across diverse organisms.
Cofactors and metal ion dependence
In simple terms: Some of these enzymes need metal ions or other small molecules to work properly.
While many tRNA-specific ribonucleases function without metal ions, some require divalent cations for optimal activity. For instance, mitochondrial tRNA processing enzymes may depend on magnesium or manganese ions for catalysis. The MazF-mt9 toxin does not appear to require metal ions for its tRNA-specific endonuclease activity, as its structure lacks a metal-binding site. In contrast, angiogenin's activity is modulated by its interaction with ribonuclease inhibitor, a protein that binds tightly and inhibits its ribonuclease activity. These variations underscore the diversity of cofactor requirements among tRNA-specific ribonucleases.
Regulation by inhibitor proteins and antitoxins
In simple terms: The activity of these enzymes can be switched off by partner proteins that bind and block them.
tRNA-specific ribonucleases are often regulated by cognate inhibitor proteins. Colicin E5 is inhibited by its immunity protein, which binds with high affinity and prevents tRNA cleavage, as revealed by structural studies. In bacterial toxin-antitoxin systems, MazF-mt9 is neutralized by its antitoxin, which sequesters the toxin and prevents tRNA degradation. In humans, angiogenin is inhibited by ribonuclease inhibitor (RNH1), a cytosolic protein that binds angiogenin and blocks its tRNA-specific ribonuclease activity, thereby protecting cells from uncontrolled tRNA cleavage. This regulation is crucial for preventing aberrant tRNA degradation under normal conditions.
tRNA processing and maturation pathways
In simple terms: These enzymes trim precursor tRNAs to their mature form by removing extra sequences.
During tRNA maturation, endonucleases and exonucleases remove 5' leader and 3' trailer sequences. In Saccharomyces cerevisiae, pre-tRNA 3'-processing involves distinct exo- and endoribonucleases that cleave after the discriminator base and trim the trailer. In bacteria, the co-evolution of tRNA 3' trailer sequences with 3' processing enzymes ensures efficient and accurate maturation. Human mitochondrial tRNA processing requires tRNA-specific ribonucleases that recognize mitochondrial tRNA structures and remove leader sequences. Defects in these processing steps can lead to accumulation of unprocessed tRNAs and mitochondrial dysfunction.
Stress-induced tRNA cleavage and fragment generation
In simple terms: Under stress, cells cut tRNAs into small pieces that can send signals or stop protein production.
Under stress conditions, tRNA-specific ribonucleases such as angiogenin cleave mature tRNAs to generate tRNA-derived stress-induced fragments (tiRNAs). These fragments can inhibit translation and promote cell survival or death depending on context. In mitochondria, tRNA cleavage by tRNA-targeting ribonucleases causes mitochondrial dysfunction, as observed in mitochondrial disease models. Bacterial toxins like MazF-mt9 also cleave tRNAs to inhibit translation during stress, contributing to persistence and virulence. This stress-induced cleavage is a conserved response that links tRNA-specific ribonuclease activity to cellular stress adaptation.
Key Genes Involved in GO:0004549 tRNA-specific ribonuclease activity
The following genes and proteins represent key examples of tRNA-specific ribonuclease activity across species, with established roles in tRNA processing, stress responses, and disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ANG | Human angiogenin, a tRNA-specific ribonuclease in the RNase A superfamily; cleaves tRNA to produce tiRNAs | Studied for roles in angiogenesis, cancer, and neurodegeneration; target for therapeutic inhibition |
| MazF-mt9 | tRNA-specific endonuclease toxin from Mycobacterium tuberculosis; cleaves tRNA to inhibit translation | Model for bacterial toxin-antitoxin systems and antimicrobial target |
| Colicin E5 | tRNA-specific ribonuclease produced by E. coli; cleaves tRNA anticodon loop | Studied for toxin-immunity protein interactions and antibacterial strategies |
| RNH1 | Ribonuclease inhibitor that binds and inhibits angiogenin's tRNA-specific ribonuclease activity | Regulator of angiogenin; potential target for modulating tRNA cleavage |
| Mitochondrial tRNA processing nucleases | Enzymes that process mitochondrial tRNAs, including endonucleases and exonucleases | Linked to mitochondrial disease; models for studying tRNA processing defects |
| S. cerevisiae pre-tRNA 3' processing enzymes | Exo- and endoribonucleases that remove 3' trailers from pre-tRNA | Model for eukaryotic tRNA maturation and enzyme specificity |
| Bacterial 3' processing enzymes | Enzymes that trim tRNA 3' trailers; co-evolve with tRNA sequences | Used to study tRNA-enzyme co-evolution and bacterial translation |
| T-box riboswitch-associated factors | Regulate methionine biosynthesis via initiator tRNA-specific T-box riboswitch in Staphylococcus aureus | Model for tRNA-dependent gene regulation and antibiotic targets |
| Other RNase A superfamily members | Some exhibit tRNA-specific ribonuclease activity or related functions | Comparative studies of substrate specificity and evolution |
| tRNA-targeting ribonucleases in mitochondria | Cleave mitochondrial tRNAs under stress, causing dysfunction | Models for mitochondrial disease and stress responses |
| MazF family toxins | Endoribonucleases that cleave tRNA or mRNA; MazF-mt9 is tRNA-specific | Studied for bacterial persistence and toxin-antitoxin biology |
| Colicin immunity proteins | Bind and inhibit colicin E5 tRNA-specific ribonuclease activity | Model for protein-protein inhibition and specificity |
| Pre-tRNA processing endonucleases | Endonucleases that cleave pre-tRNA at specific sites during maturation | Used to dissect tRNA processing pathways |
| Pre-tRNA processing exonucleases | Exonucleases that trim pre-tRNA ends during maturation | Studied for their roles in tRNA quality control |
| Mitochondrial tRNA cleavage factors | Proteins that mediate tRNA cleavage in mitochondria | Linked to mitochondrial dysfunction and disease |
| Bacterial tRNA 3' processing enzymes | Enzymes that remove 3' trailers from bacterial tRNAs | Model for co-evolution of tRNA sequences and processing enzymes |
| Angiogenin variants | Mutants of ANG with altered tRNA-specific ribonuclease activity | Used to study structure-function relationships and disease associations |
| Ribonuclease inhibitor variants | Mutants of RNH1 that affect angiogenin inhibition | Tools for probing regulation of tRNA cleavage |
How Is tRNA-specific ribonuclease activity Regulated?
The activity of tRNA-specific ribonucleases is tightly regulated at multiple levels. In humans, angiogenin is inhibited by ribonuclease inhibitor (RNH1), which binds with high affinity and blocks its tRNA-specific ribonuclease activity, preventing uncontrolled tRNA cleavage under normal conditions. Under stress, angiogenin is released from RNH1 and cleaves tRNA to generate tiRNAs, which modulate translation. In bacteria, toxin-antitoxin systems regulate MazF-mt9; the antitoxin binds and neutralizes the toxin, but under stress, the antitoxin is degraded, freeing MazF-mt9 to cleave tRNA. Colicin E5 activity is regulated by its cognate immunity protein, which binds and inhibits the ribonuclease, protecting the producing cell from self-intoxication. Additionally, the expression of tRNA processing enzymes can be regulated at the transcriptional level, as seen in the T-box riboswitch controlling methionine biosynthesis genes in Staphylococcus aureus, which responds to initiator tRNA levels. These regulatory mechanisms ensure that tRNA-specific ribonuclease activity is deployed only when needed, preventing deleterious tRNA degradation.
tRNA-specific ribonuclease activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ANG | Cancer, angiogenesis, ALS | Knockout and point-mutation models in cancer cell lines; overexpression in endothelial cells |
| MazF-mt9 | Tuberculosis pathogenesis, antibiotic tolerance | Knockout of mazF-mt9 in M. tuberculosis; overexpression in E. coli |
| Colicin E5 | Bacterial growth inhibition, toxin-antitoxin | Knockout of colicin E5 in E. coli; immunity protein knockout |
| Mitochondrial tRNA processing nucleases | Mitochondrial disease | Knockout in human cell lines; point mutations mimicking disease variants |
| RNH1 | Regulation of angiogenesis and stress response | Knockout and overexpression in mammalian cells |
Mitochondrial disease and tRNA processing defects
Defects in mitochondrial tRNA processing by tRNA-specific ribonucleases can lead to mitochondrial dysfunction, which is observed in mitochondrial disease. Studies have shown that mitochondrial tRNA cleavage by tRNA-targeting ribonucleases causes mitochondrial dysfunction, contributing to the pathology of mitochondrial diseases. Human mitochondrial tRNA processing requires specific ribonucleases, and mutations in these enzymes or in tRNA genes can impair processing, leading to accumulation of unprocessed tRNAs and respiratory chain defects. These findings link GO:0004549 to mitochondrial disorders and highlight the importance of proper tRNA maturation for cellular energy metabolism.
Cancer and angiogenesis
Angiogenin, a tRNA-specific ribonuclease, is a potent inducer of angiogenesis and is upregulated in various cancers. Its tRNA-specific ribonuclease activity is cytotoxic and generates tiRNAs that promote cell survival under stress, contributing to tumor growth and metastasis. Inhibition of angiogenin's ribonuclease activity reduces angiogenesis and tumor growth in experimental models, making it a potential therapeutic target. Thus, GO:0004549 is directly implicated in cancer biology through angiogenin's dual roles in tRNA cleavage and angiogenesis.
Bacterial pathogenesis and toxin-antitoxin systems
Bacterial pathogens utilize tRNA-specific ribonucleases as toxins to inhibit translation and promote persistence. MazF-mt9 from Mycobacterium tuberculosis is a tRNA-specific endonuclease that cleaves tRNA, leading to growth arrest and antibiotic tolerance. Colicin E5 is a tRNA-specific ribonuclease that kills sensitive E. coli cells by cleaving tRNA, and its immunity protein protects the producing cell. These systems are attractive targets for novel antimicrobials, as inhibiting tRNA-specific ribonucleases could disarm bacterial toxins and restore translation.
Neurodegeneration and stress responses
Angiogenin mutations have been linked to amyotrophic lateral sclerosis (ALS), and its tRNA-specific ribonuclease activity is thought to contribute to motor neuron degeneration under stress. Stress-induced tRNA cleavage by angiogenin generates tiRNAs that can trigger cell death pathways, and dysregulation of this process may contribute to neurodegeneration. Understanding how GO:0004549 is regulated in neurons could provide insights into ALS pathogenesis and potential therapeutic strategies.
From tRNA-specific ribonuclease activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ANG tRNA-specific ribonuclease activity affect angiogenesis? | ANG knockout in endothelial cells or zebrafish |
| How do point mutations in ANG alter tRNA cleavage and neurotoxicity? | Point-mutation knock-in in motor neuron models |
| What is the role of MazF-mt9 in M. tuberculosis persistence? | MazF-mt9 knockout in M. tuberculosis |
| How does colicin E5 immunity protein inhibit tRNA cleavage? | Knock-in of immunity protein mutants in E. coli |
| What are the effects of mitochondrial tRNA processing defects? | Knockout of mitochondrial tRNA processing nucleases in human cells |
| Can overexpression of tRNA-specific ribonucleases induce stress responses? | Overexpression of ANG or MazF-mt9 in mammalian or bacterial cells |
How to Study the tRNA-specific ribonuclease activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro ribonuclease assay | Cleavage of tRNA substrates by purified enzymes | Characterizing enzyme activity and mutants |
| X-ray crystallography | Three-dimensional structure of enzyme-tRNA complexes | Understanding substrate recognition and inhibition |
| RNA-seq / tRNA-seq | tRNA cleavage products and tiRNA levels | Profiling stress-induced tRNA cleavage |
| Northern blot | Specific tRNA fragment sizes | Validating cleavage sites |
| CRISPR knockout screens | Genes affecting tRNA ribonuclease activity or toxicity | Identifying regulators and therapeutic targets |
| CRISPR activation screens | Genes whose overexpression modulates tRNA cleavage | Discovering enhancers of ribonuclease activity |
| Mass spectrometry | Protein interactions and post-translational modifications | Identifying regulators of tRNA-specific ribonucleases |
| Fluorescence microscopy | Localization of tRNA-specific ribonucleases | Studying subcellular distribution under stress |
Biochemical ribonuclease assays
In vitro ribonuclease assays using purified tRNA substrates are the gold standard for measuring tRNA-specific ribonuclease activity. These assays typically incubate the enzyme with radiolabeled or fluorescently labeled tRNA and analyze cleavage products by gel electrophoresis or HPLC. Such assays have been used to characterize angiogenin's tRNA-specific activity and to determine the effects of mutations in its catalytic site. They are also used to study MazF-mt9 and colicin E5 activity and inhibition by their cognate immunity proteins.
Structural biology (X-ray crystallography and cryo-EM)
Structural studies provide atomic-level insights into how tRNA-specific ribonucleases recognize and cleave tRNA. X-ray crystallography of MazF-mt9 revealed a compact dimer with a catalytic triad and tRNA-binding surface. The structure of colicin E5 in complex with its immunity protein showed how the inhibitor occludes the active site. These structures guide mutational analysis and drug design targeting tRNA-specific ribonucleases.
RNA sequencing and tRNA fragment analysis
RNA-seq and specialized tRNA-seq methods can quantify tRNA cleavage products and tRNA-derived fragments (tiRNAs) in cells. These approaches have been used to detect angiogenin-mediated tRNA cleavage under stress and to profile changes in tRNA pools upon mitochondrial dysfunction. Northern blotting and small RNA sequencing are commonly used to validate specific tRNA cleavage events.
CRISPR-based genetic screens
CRISPR knockout and activation screens can identify genes that regulate tRNA-specific ribonuclease activity or mediate its downstream effects. For example, genome-wide screens can uncover modifiers of angiogenin toxicity or tRNA processing defects. Such screens are powerful for discovering novel regulators and therapeutic targets related to GO:0004549.
How CRISPR Can Be Used to Study GO:0004549 tRNA-specific ribonuclease activity
Knockout
CRISPR knockout of genes encoding tRNA-specific ribonucleases, such as ANG or MazF-mt9, allows researchers to assess their loss-of-function phenotypes. For example, ANG knockout in human cells reduces stress-induced tRNA cleavage and tiRNA production, affecting cell survival and angiogenesis. Knockout of MazF-mt9 in Mycobacterium tuberculosis can attenuate persistence and antibiotic tolerance. These models are essential for establishing causality between tRNA-specific ribonuclease activity and biological outcomes.
Point Mutation
CRISPR point mutation can introduce catalytic-dead mutations in tRNA-specific ribonucleases to dissect the contribution of enzymatic activity versus other functions. For instance, mutating the catalytic histidine residues in angiogenin abolishes its tRNA-specific ribonuclease activity, allowing separation of its ribonuclease-dependent and independent roles. Similar point mutations in MazF-mt9 can clarify its toxic effects. These models are valuable for understanding structure-function relationships.
Knock-in
CRISPR knock-in can introduce disease-associated mutations or tags into endogenous tRNA-specific ribonuclease genes. For example, knocking in ALS-associated ANG mutations into motor neurons can model neurodegeneration and assess changes in tRNA cleavage. Tagged knock-in of MazF-mt9 with a fluorescent protein enables real-time tracking of toxin localization and activity in bacteria. These models provide physiological relevance and precise regulation.
Overexpression
CRISPR activation or transgenic overexpression of tRNA-specific ribonucleases can induce stress responses and tRNA cleavage. Overexpression of angiogenin in endothelial cells promotes angiogenesis and generates tiRNAs. Overexpression of MazF-mt9 in E. coli inhibits growth by cleaving tRNA. These models are useful for studying gain-of-function effects and identifying downstream pathways.
How EDITGENE Supports tRNA-specific ribonuclease activity Research
Researchers studying tRNA-specific ribonuclease activity-related genes often need to determine whether a candidate gene is causally involved in tRNA processing, stress responses, or disease. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling precise functional interrogation of GO:0004549 and its regulators.
Contact EDITGENE today to design your custom CRISPR model for tRNA-specific ribonuclease activity research.
Frequently Asked Questions About tRNA-specific ribonuclease activity
What is tRNA-specific ribonuclease activity?
tRNA-specific ribonuclease activity (GO:0004549) is the catalysis of phosphodiester bond hydrolysis in tRNA molecules, essential for tRNA maturation, quality control, and stress-induced cleavage.
What genes are involved in tRNA-specific ribonuclease activity?
Key genes include ANG (angiogenin), MazF-mt9, colicin E5, and mitochondrial tRNA processing nucleases, among others.
How is tRNA-specific ribonuclease activity regulated?
It is regulated by inhibitor proteins such as RNH1 for angiogenin, antitoxins for MazF-mt9, and immunity proteins for colicin E5.
What diseases are associated with tRNA-specific ribonuclease activity?
Diseases include mitochondrial disease, cancer, ALS, and bacterial infections linked to toxin-antitoxin systems.
What methods are used to study tRNA-specific ribonuclease activity?
Common methods include in vitro ribonuclease assays, X-ray crystallography, RNA-seq, Northern blot, and CRISPR screens.
How does angiogenin relate to tRNA-specific ribonuclease activity?
Angiogenin is a human tRNA-specific ribonuclease that cleaves tRNA to generate tiRNAs, and its activity is linked to angiogenesis and neurodegeneration.
What is the role of MazF-mt9 in tRNA cleavage?
MazF-mt9 is a tRNA-specific endonuclease from Mycobacterium tuberculosis that cleaves tRNA to inhibit translation and promote persistence.
How does colicin E5 inhibit bacterial growth?
Colicin E5 is a tRNA-specific ribonuclease that cleaves tRNA in sensitive E. coli cells, leading to growth arrest; its immunity protein protects the producing cell.
Can CRISPR be used to study tRNA-specific ribonuclease activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies of genes involved in tRNA-specific ribonuclease activity.
What are tiRNAs and how are they related to tRNA-specific ribonucleases?
tiRNAs are tRNA-derived stress-induced fragments generated by tRNA-specific ribonucleases such as angiogenin; they regulate translation and cell survival.
Conclusion
tRNA-specific ribonuclease activity (GO:0004549) is a fundamental molecular function that governs tRNA maturation, quality control, and stress-induced cleavage across all domains of life. Its dysregulation is linked to mitochondrial disease, cancer, neurodegeneration, and bacterial pathogenesis, making it a compelling target for therapeutic intervention. Advances in CRISPR-based models and RNA sequencing technologies are accelerating our understanding of this activity and its regulatory networks. EDITGENE's comprehensive services empower researchers to dissect the roles of tRNA-specific ribonucleases with precision and efficiency.
References
- 1. Saxena SK et al.. 1992. Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily.. J Biol Chem 267(30):21982-6 PMID: 1400510
- 2. Ogawa T et al.. 2014. Mitochondrial tRNA cleavage by tRNA-targeting ribonuclease causes mitochondrial dysfunction observed in mitochondrial disease.. Biochem Biophys Res Commun 451(1):131-6 PMID: 25065742
- 3. Rossmanith W et al.. 1995. Human mitochondrial tRNA processing.. J Biol Chem 270(21):12885-91 PMID: 7759547
- 4. Chen R et al.. 2017. Structure of the MazF-mt9 toxin, a tRNA-specific endonuclease from Mycobacterium tuberculosis.. Biochem Biophys Res Commun 486(3):804-810 PMID: 28351618
- 5. Luna-Chávez C et al.. 2006. Molecular basis of inhibition of the ribonuclease activity in colicin E5 by its cognate immunity protein.. J Mol Biol 358(2):571-9 PMID: 16524591
- 6. Papadimitriou A et al.. 1996. Pre-tRNA 3'-processing in Saccharomyces cerevisiae. Purification and characterization of exo- and endoribonucleases.. Eur J Biochem 242(3):747-59 PMID: 9022706
- 7. Schoenfelder SM et al.. 2013. Methionine biosynthesis in Staphylococcus aureus is tightly controlled by a hierarchical network involving an initiator tRNA-specific T-box riboswitch.. PLoS Pathog 9(9):e1003606 PMID: 24068926
- 8. Li Z et al.. 2005. Co-evolution of tRNA 3' trailer sequences with 3' processing enzymes in bacteria.. RNA 11(5):567-77 PMID: 15811923
